Bryce Point Capital, LLC Charles River Laboratories International, Inc. Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 2,898 shares of CRL stock, worth $446,292. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,898Holding current value
$446,292% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$948 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$784 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$628 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$328 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$299 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.83B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...